Galenica Business Model Canvas

Operate Amavita, Coop Vitality and Sun Store across over 480 pharmacies (2024), enforcing uniform service standards and regulatory compliance. Manage prescription dispensing, patient counselling and front-of-store retail workflows to ensure safe, efficient care. Tailor assortment, pricing and promotions by location using sales and customer-data analytics. Deliver vaccinations, point-of-care tests and minor-ailment services as core clinical offerings.

Procure, store, and distribute medicines and healthcare goods nationwide, operating under Good Distribution Practice (GDP) and the EU Falsified Medicines Directive serialization requirements established in 2019. Maintain batch-level tracking and cold-chain integrity (typical vaccine range 2–8°C) across warehouses and transport. Execute next-day or same-day deliveries to pharmacies, doctors, and hospitals. Manage returns, recalls, and serialized traceability for patient safety.

Amavita, Coop Vitality and Sun Store give Galenica national reach and consumer trust, supported in 2024 by a network of over 600 pharmacies; prime locations drive high footfall and convenience for urban and regional customers. Their established brand equity enables rollout of premium services and higher-margin offerings, while standardized operations and SOPs ensure consistent patient experiences across sites.

Distribution infrastructure—warehouses, dedicated fleets and cold-chain assets—ensure reliable supply, supporting Galenica Group which reported CHF 3.7 billion revenue in 2023. Advanced WMS and automation boost picking accuracy and throughput. Broad geographic coverage enables fast B2B delivery while layered redundancy across sites cuts disruption risk.

Galenica's extensive retail and wholesale network (about 580 pharmacies in 2024) reduces stockouts and enables same-day or next-day delivery for urgent needs; cold-chain and GDP-compliant logistics preserve product quality, and consistent supply has driven sustained trust from patients and providers across Switzerland.

Pharmacist counseling, vaccinations and point-of-care testing deliver measurable clinical value, supporting preventive care and medication adherence across Galenica’s network of over 600 locations (2024). Long opening hours and dense urban coverage increase convenience and footfall. Digital tools power e-prescriptions and click-and-collect, with growing digital prescription adoption in 2024. Multilingual service improves accessibility for Switzerland’s diverse population.

Face-to-face counseling builds trust and loyalty, addressing WHO data that adherence to long-term therapies averages about 50% in developed countries. Medication reviews and adherence support by pharmacists are linked in multiple studies to fewer adverse events and reduced hospital readmissions. Staff recognize repeat customers and tailor advice, while systematic feedback capture (surveys, POS data) refines services and drives retention.

Points, coupons and targeted offers boost retention and repeat purchases; tailored promotions increase engagement across pharmacy and digital channels. Tiered benefits drive higher spend and frequency by rewarding loyalty with escalated perks. Integrated digital accounts simplify tracking and redemption, enabling real-time personalization. According to Bain, a 5% increase in retention can raise profits 25–95%, underscoring data-driven promotions.

Amavita, Coop Vitality and Sun Store form Galenica’s primary retail touchpoints, with a combined network of over 700 outlets in 2024 driving footfall and prescription volumes. High-traffic locations concentrate sales and accelerate uptake of services such as vaccination and screening, contributing materially to retail margins. In-store clinics and counseling counters broaden care offerings and increase basket size. Targeted merchandising and category placement support cross-sell of OTC, beauty and care products.

Online pharmacy and app enable ordering of Rx where permitted and OTC items via a unified platform, increasing accessibility and prescription adherence.

Click-and-collect plus home delivery add convenience and reduce churn, supported by 95% smartphone penetration in Switzerland in 2024.

Digital wallets and loyalty integration streamline checkout and boost AOV; app-based loyalty ties purchases across channels.

Educational content and guided self-care tools drive informed decisions and higher digital engagement.

Retail consumers and patients seek prescriptions, OTC and wellness products, valuing convenience, expert advice and fair pricing; they engage via Galenica’s stores and digital channels and are sensitive to service quality and availability. Galenica served this market with around 600 retail outlets and roughly 6,800 employees in 2024, within a Swiss population of about 8.77 million.

Chronic and high-need patients require regular refills, adherence support and continuous monitoring; non-adherence affects about 50% of long-term therapies (WHO 2024). They benefit from counseling and structured medication reviews to reduce errors and costs, as chronic conditions account for roughly 70% of healthcare burden (WHO 2024). Prefer home delivery, automatic reminders and stability—reliability is paramount for retention and outcomes.

Purchases of Rx, OTC and health products make up the bulk of Galenica’s cost of goods sold, typically around 80–90% of total COGS, and price volatility plus manufacturer rebates can swing gross margins by several hundred basis points annually.

Strategic own‑brand sourcing reduces unit costs by roughly 5–15% versus third‑party branded products while preserving quality control and margin upside.

Serialization and regulatory packaging add discrete overhead estimated at about €0.03–0.08 per pack under EU/FMD‑style regimes, increasing per‑unit COGS and logistics complexity.

Galenica labor costs cover pharmacists, technicians, drivers and support teams; 2024 Swiss median salaries approximate CHF 95,000 for pharmacists, CHF 55,000 for technicians and CHF 60,000 for drivers, driving a substantial payroll line. Training and compliance consume material time—typical pharmacy CPD averages 20–40 hours/year—adding direct cost and downtime. Variable staffing models scale up ~20–25% during trading peaks to match demand. Benefits and retention programs (roughly 12–18% of payroll) sustain service quality.

Revenue derives from insurer reimbursements plus patient co-pays for dispensed prescriptions, with 2024 volumes boosted by chronic-therapy renewals and rising e-prescription use. Service fees for medication reviews or clinical checks can add per-transaction income, typically negotiated with payers. Margins in 2024 are pressured by statutory tariffs and the mix shift between higher-margin branded drugs and lower-margin generics.

Front-of-store OTC, wellness and beauty assortments drive cash sales and increase basket size by capturing impulse and convenience purchases at point of care. Seasonal demand (allergy season, flu wave, summer skincare) shapes targeted promotions and inventory rotation. Private-label ranges improve gross margin and price competitiveness. Cross-selling with in-store clinical services and consultations consistently boosts average transaction uplift.